baber/WOPTO huggingface dataset:
Patent SK-285483-B6 (SK)
Title: Modification of motor fuel system with injection to measure the fuel consumption
Inventor: PODSTANICKY IVAN
IPC: F02M19/00
Filed: 2002-05-20
Abstract: In a circulation field of a fuel injector (7) is between an induction pipe (6) and a bypass pipe (8) inserted an antifoaming tank (5) that is coupled by a feed pipe (2) with a fuel tank (1), whereby in the bypass pipe (8) is placed a cooler (11).
Patent CZ-296616-B6 (CZ)
Title: Instrument support member
Inventor: MAINKA CHRISTOPH
IPC: B62D25/14
Filed: 2001-03-23
Abstract: The present invention relates to an instrument support member (1) with an integrated air conducting unit to be mounted between the front columns of a motor vehicle is composed of at least two metal shells (5, 6), which are connected to each other by plasma jet welding with an effective focus remote from the nozzle, and a plastic tube (2) surrounded by the shells (5, 6) wherein said plastic tube (2) is mounted at a certain radial distance from the shells (5, 6).
Patent CZ-297386-B6 (CZ)
Title: N-[2-hydroxy-3-(1-piperidinyl)propoxy]pyridine-1-oxide-3-carboximidoyl chloride and use thereof when treating resistance to insulin and pharmaceutical preparations in which the chloride is comprised
Inventor: KUERTHY MARIA
IPC: A61K31/44
Filed: 2000-02-24
Abstract: N-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride, its stereoisomers, and the addition salts thereof, pharmaceutical compositions containing the same, methods of treating pathological insulin resistance, methods of treating pathological insulin resistance and pathological conditions associated therewith, and methods of treating pathological insulin resistance by simultaneously treating diabetes-induced chronic complications, especially retinopathy, neuropathy and nephropathy, and/or by simultaneously increasing pathologically decreased peripheral neuroregeneration caused by diabetes.
Patent CZ-296485-B6 (CZ)
Title: Preparation containing ibuprofen as active substance
Inventor: EINIG HEINZ
IPC: A61K31/19
Filed: 2001-01-19
Abstract: The present invention relates to a preparation containing as active substance ibuprofen, further to a process for preparing such a preparation as well as the use thereof in the preparation of pharmaceutical compositions.
Patent SK-287405-B6 (SK)
Title: Caloporoside derivatives, medicaments containing them, method for the production thereof by a microorganism and a microorganism
Inventor: EDER CLAUDIA
IPC: A61P35/00
Filed: 2002-02-23
Abstract: Disclosed are compounds of a general formula (I), in which R1, R2 and R3 are, independently of one another, hydrogen atom or acyl group having 2 to 10 carbon atoms; and R4 is hydrogen atom or -C(O)(CH2)nCOOH in which n is 1 to 7; with the exception that R1, R2, R3 and R4 are not all hydrogen atom, as well as physiologically acceptable salts thereof, medicaments containing them for the treatment of cancer diseases, process for the preparation of said compounds by fermentation of the microorganism Gloeoporus dichrous (Fr. : Fr.) Bres. ST 001714, DSM 13784, or one of its variants or mutants, and said microorganism.
Patent SK-287296-B6 (SK)
Title: Pyrimidine-4-one derivatives, pharmaceutical compositions containing them and their use
Inventor: HICKEY DEIRDRE MARY BERNADETTE
IPC: C07D239/70
Filed: 2001-02-13
Abstract: Pyrimidinone compounds of the general formula (IB) as inhibitors of the enzyme Lp-PLA2, pharmaceutical compositions containing them and their use in the treatment of atherosclerosis.
Patent SK-288763-B6 (SK)
Title: Metal strips and method of their production
Inventor: SCHUSTER ROLAND
IPC: C21D9/00
Filed: 2015-10-30
Abstract: A metal strip is disclosed, where the strip in addition to Fe comprises 0.01 % - 0.2 % of C, 12 % - 18 % of Cr, 4 % - 8 % of Ni, 0 % - 3.5 % of Cu, 0 % - 0.5 % of Ti, 0 % 1.8 % of Si and 0 % - 2 % of Mn. It is also disclosed a method of production of the strips involving the following steps: Preparation of metal strip material having in advance given thickness and length; heating the strip until pre-annealing temperature between 90 °and 150°C is attained; following uniform heating from pre-annealing temperature to the temperature, that is lower by a value between 5 °C and 60 °C than predetermined final temperature during the time between 2 hours and 4 hours, wherein the final temperature is between 450 °C and 700 °C; following uniform heating to the final temperature during the time between 0,1 hour to 1 hour; holding the final temperature during 0.5 hour - 2.5 hours; cooling to the post-annealing temperature between 200 °C and 400 °C during the time between 0.5 hour – 2.5 hour, and following cooling from the post-annealing temperature to the temperature of the room.
Patent BR-PI0113942-B8 (BR)
Inventor: JAN VAN KRIEKEM
IPC: C07C59/08
Filed: 2001-09-14
Abstract: The invention relates to a method for the purification of a fermentatively prepared alpha-hydroxy acid on an industrial scale, in which an alpha-hydroxy acid with a color (fresh) of not more than 10,000 APHA units is subjected to at least two crystallization steps, with the crystallization steps being carried out in cooling crystallization devices, melting crystallization devices, evaporative crystallization devices and/or adiabatic crystallization devices.
Patent BR-PI9913138-B8 (BR)
Title: derivado de quinolin-2-ona substituído com alquinila e composição farmacêutica contendo o mesmo
Inventor: LYSSIKATOS JOSEPH PETER
IPC: A61K31/47
Filed: 1999-08-06
Abstract: patente de invenção: <b>"derivados de quinolin-2-ona substituídos com alquinila úteis como agentes contra o câncer"<d>. a presente invenção refere-se a composto da fórmula 1 e a seus sais, pró-drogas e solvatos farmaceuticamente aceitáveis, em que r¹, r², r^ 4^, r^ 5^, r^ 6^, r^ 7^, r^ 8^, r^ 9^, r^ 10^ e r^ 11^ são tais como aqui se definem. os composto acima da fórmula 1 são úteis no tratamento de distúrbios hiperproliferativos, tais como câncer, em mamíferos. a invenção também refere-se a composições farmacêuticas que contêm compostos da fórmula 1 e a métodos para a inibição do crescimento anormal das células, incluindo o câncer, em mamíferos, pela administração de compostos da fórmula 1, a mamíferos que tenham necessidade de tal tratamento.
Patent EP-1353684-B8 (EP)
Title: Use of inhibitors of dipeptidypeptidase iv (ec 3.3.14.5) and aminopeptidase n (ec 3.4.11.2) for the treatment of neurodegeneration induced by ischaemia
Inventor: ANSORGE SIEGFRIED
IPC: A61P25/00
Filed: 2001-12-21
Granted: 2011-09-28
Abstract: The invention relates to a method which reduces or prevents lesions to cerebral tissues after ischaemia or brain/cerebral traumas, involving the separate or combined administration and effect of enzyme inhibitors of alanyl-aminopeptidase (APN) and dipeptidylpeptidase IV (DP IV) or enzymes having the same similar substrate specificity.  The invention demonstrates that in order to prevent or treat the above-mentioned indications, the separate or combined application of inhibitors of the above-mentioned enzymes or corresponding preparations and forms of administration are suitable.
Patent EP-1869513-B8 (EP)
Inventor: TAMMELA SIMO
IPC: G02B6/04
Filed: 2006-02-23
Granted: 2010-10-27
Abstract: The invention relates to a bundle for fiber lasers, wherein two optical fibers (10, 14) attached to each other exclusively by a removable bridging element (11) along a section of their length, the two optical fibers being freed from each other in at least another section of their length. The bridging element comprising silica glass, which has a refractive index essentially the same to that of a material of an outer layer of the two optical fibers, and the bridging element is a sacrificial layer (19) deposited on only one of the two optical fibers, a material of the sacrificial layer being doped so as to increase a wet etching speed of the sacrificial layer as compared to a material of the two optical fibers in order to be more easily removable.
Patent EP-2109517-B8 (EP)
Inventor: WEBB STEVEN PAUL
IPC: B25B27/10
Filed: 2008-01-31
Granted: 2012-03-21
Abstract: A tool (20) for a pipe fitting arrangement in which a pipe is retainable arranged within a housing (1) by teeth (13) of a grip ring (12) placed within the housing, the tool comprising: first engagement means for engaging the pipe, said first engagement means having at least one part (12) adapted to enter the housing around the pipe in order to force the teeth of the grip ring out of engagement with the pipe, second engagement means for engaging the first engagement means as well as the housing in order to locate the housing relative to the tool, and a handle connected or connectable with the second engagement means. The first engagement means being connected to the second engagement means via at least one first joint being in form of a pivot (24f) and/or at least one first spring means (38) in order to be at least partly displaceable relative to the second engagement means, and a method using such a tool.
Patent BR-PI0309992-B8 (BR)
Inventor: MAKONNEN BELEW
IPC: C07K14/765
Filed: 2003-05-09
Abstract: The present invention is a method of purifying recombinant human serum albumin (rHSA) from a solution, which method comprises to subject a cell culture supernatant (CCS) comprising rHSA cation exchange on a bimodal high salt tolerant matrix; hydrophobic interaction chromatography (HIC); anion exchange; and recovering the purified rHSA. The bimodal high salt tolerant cation exchange matrix used enables performing a purification of a cell culture supernatant directly, in the sense that no further dilution thereof is necessary. Due to its high binding capacity, said bimodal cation exchange matrix also allows use of a smaller amount of matrix as compared to a corresponding conventional cation exchanger matrix. Accordingly, the present invention allows substantial savings as regards volumes and consequently operation costs.
Patent BR-PI0709235-B8 (BR)
Title: decodificador de áudio, método de decodificação de áudio, receptor para receber um sinal de n canais, sistema de transmissão para transmitir um sinal de áudio, método para receber um sinal de áudio, método para transmitir e receber um sinal de áudio, mídia de armazenamento legível por computador, e, dispositivo de reprodução de áudio
Inventor: ERIK G P SCHUIJERS
IPC: G10L19/02
Filed: 2007-03-23
Abstract: decodificador de áudio, método de decodificação de áudio, receptor para receber um sinal de n canais, sistema de transmissão para transmitir um sinal de áudio, método para receber um sinal de áudio, método para transmitir e receber um sinal de áudio, produto de programa de computador, e, dispositivo de reprodução de áudio. um decodificador de áudio inclui um receptor (801) para receber dados de entrada compreendendo um sinal de n canais correspondendo a um sinal mixado descendentemente de um sinal de áudio de m canais, m > n, tendo matrizes de codificação de sub-banda de valor complexo aplicadas em sub-bandas de freqúência e dados de multicanais paramétricos. um banco de filtro de sub-banda (805) gera sub-bandas de frequência de valor real para o sinal de n canais. um processador de matriz (809) determina matrizes de decodificação de sub-banda de valor real para compensar a aplicação das matrizes de codificação em resposta aos dados de multicanais paramétricos. um processador de compensação (807) gera dados de mixagem descendente correspondendo ao sinal mixado descendentemente por uma multiplicação de matriz das matrizes de decodificação de sub-banda de valor real e dados do sinal de n canais nas pelo menos algumas sub-bandas de freqtiência de valor real. os dados de mixagem descendente podem ser usados para regenerar o sinal mixado descendentemente e o sinal de áudio de m canais. o decodificador pode compensar as operações de compatibilidade envolvente de matriz de mpeg executadas no codificador usando sub-bandas de frequência de valor real.
Patent BR-PI0809446-B8 (BR)
Title: Método de determinação da presença ou quantidade de glifosato, n-acetilglifosato, ácido n-acetilaminometifosfônico (n-acetil ampa), ou ácido de fosfônico aminometil (ampa) em uma amostra de teste e método de purificação de pelo menos glifosato, n-acetil ampa ou n-acetilglifosato do ampa
Inventor: FREDERICK Q BRAMBLE JR
IPC: C07F9/38
Filed: 2008-03-25
Abstract: MÉTODO DE DETERMINAÇÃO DA PRESENÇA OU QUANTIDADE DE GLIFOSATO, N-ACETILGLIFOSATO, ÁCIDO N-ACETILAMINOMETIFOSFÔNICO (N-ACETIL AMPA), OU ÁCIDO DE FOSFÔNICO AMINOMETIL (AMPA) EM UMA AMOSTRA DE TESTE E MÉTODO DE PURIFICAÇÃO DE PELO MENOS GLIFOSATO, N-ACETIL AMPA OU N-ACETILGLIFOSATO DO AMPA A presente invenção fornece vários métodos e composições que permitem a determinação da presença ou da quantidade de glifosato, N-acetilglifosato, N-acetil ou AMPA ou ácido fosfórico aminometil (AMPA) e seus metabólitos em uma variedade de matrizes de teste. Em um método, que determina a presença ou quantidade de N-acetilglifosato e/ou Nacetil AMPA em uma amostra de teste que consiste em fornecer a amostra de teste que contém N-acetilglifosato e/ou N-acetil AMPA; a extração de uma composição que consiste de N-acetilglifosato e/ou N-acetil AMPA da amostra de teste; e, a detecção de N-acetilglifosato e/ou N-acetil AMPA no extrato. Em outros métodos, é determinada a presença ou quantidade de pelo menos um glifosato, N-acetilglifosato, N-acetil AMPA ou ácido fosfônico aminometil (AMPA) ou um de seus metabólitos em uma amostra de teste. O método consiste em fornecer a amostra de teste que contém pelo menos um glifosato, N-acetilglifosato, N-acetil AMPA ou AMPA ou um dos seus metabólitos; em extrair da amostra de uma composição que consiste de pelo menos um glifosato, N-acetilglifosato, N-acetil AMPA ou AMPA ou um dos seus metabólitos, e, em detectar ao menos, um glifosato, N-acetilglifosato, N-acetil AMPA ou AMPA ou um dos seus metabólitos na amostra de teste, onde a detecção do glifosato, N-acetilglifosato, N-acetil AMPA e/ou AMPA ocorre sem derivatização do glifosato, N-acetilglifosato, N-acetil AMPA ou AMPA.
Patent BR-PI0901906-B8 (BR)
Inventor: ANDREW M ZWOLINSKI
IPC: A61B17/068
Filed: 2009-02-16
Abstract: In various embodiments, a disposable loading unit (16) for a surgical stapling instrument (10) can include an anvil (20), a staple cartridge (220), a staple cartridge channel (218) for operably supporting the staple cartridge (220), and a connector (1017) for removably attaching the disposable loading unit to the surgical instrument. In at least one embodiment, a first staple cartridge can be replaced with another staple cartridge after the first staple cartridge has been at least partially expended. In various embodiments, a staple cartridge can include a staple driver (232) for deploying staples from the staple cartridge (220) and a cutting member (280) for incising tissue, wherein a new staple driver and a new cutting member can be provided with each new staple cartridge. The anvil (20) can be removably attachable to the disposable loading unit (16) such that a new anvil can be utilized with a new staple cartridge.
Patent AU-2002217379-B8 (AU)
Title: Optical brighteners compositions, their production and their use
Inventor: TINDAL ALEC STEWART
IPC: C09B67/22
Filed: 2002-01-08
Granted: 2002-07-24
Abstract: The invention relates to an optical brightener mixture (W) comprising optical brighteners (A) of formula (Ia), and (B) of formula (Ib) and optionally (C) of formula (Ic) as defined herein, their concentrated aqueous solutions (S), their production and their use.
Patent AU-2003269946-B8 (AU)
Title: System for labeling a medicine container with a folded label
Inventor: RICE DENNIS WAYNE
IPC: G16H70/40
Filed: 2003-08-06
Granted: 2010-01-14
Abstract: Computer assisted systems, methods and mediums for filling one or more orders. One embodiment of the present invention is a system that includes an order consolidation station (215) configured to receive at least one bottle containing pills individually counted and/or at least one package containing pharmaceutical products without having been designated for any of the orders when the package was created and/or at least one literature pack optionally including patient specific information. The order consolidation station is further configured to combine automatically the received bottle and/or package and/or literature pack into a container to be sent to a recipient including, for example, mail order pharmacies, wholesalers and/or central fill dealers for subsequent distribution or sale including retailer distribution or sale. The bottle is specifically designated for the order, and the order generally includes at least one prescription for the package.
Patent AU-2007318246-B8 (AU)
Title: Heteroaryl (substituted) alkyl N-substituted sulfoximines as insecticides
Inventor: NUGENT BENJAMIN M
IPC: C07D417/06
Filed: 2007-02-09
Granted: 2013-06-20
Abstract: N-Substituted heteroaryl (substituted)alkyl sulfoximines are effective at controlling insects.
Patent BR-112013000267-B8 (BR)
Title: Métodos de introdução de uma molécula de cassete de ácido nucleico em uma célula vegetal e de introgressão de um traço em uma planta mediados por nanopartícula de ponto quântico
Inventor: KERRM Y YAU
IPC: B82Y5/00
Filed: 2011-07-07
Abstract: PRODUÇÃO DE CASSETE DE DNA LINEAR FUNCIONALIZADO E DISTRIBUIÇÃO MEDIADA POR PONTO QUÂNTICO/NANOPARTÍCULA EM PLANTAS.  A presente invenção refere-se a métodos para introdução de uma molécula de cassete de ácido nucleico linear funcionalizada de interesse em uma célula vegetal compreendendo uma parede celular que incluem o uso de nanopartículas. Em algumas modalidades, a célula compreendendo uma parede celular é uma célula vegetal cultivada. Os métodos incluem modificar geneticamente ou de outra maneira células vegetais e para tratamento ou prevenção de doença em qualquer planta, especialmente plantas de cultura. Plantas transgênicas incluem uma molécula de ácido nucleico de interesse produzida pela regeneração de plantas inteiras de células vegetais transformadas com moléculas de cassete de ácidos nucleicos lineares funcionalizadas.
Patent BR-112017002070-B8 (BR)
Title: métodos de produção de uma composição cosmética anidra, composições cosméticas anidras e método para inibir o suor e o odor de se formarem na pele
Inventor: ANNE-LAURE CARMEN PAULETTE GAUDRY
IPC: A61Q15/00
Filed: 2014-12-16
Abstract: a presente invenção trata de une composição cosmética que contém: (a) um princípio ativo antiperspirante que contém alumínio; (b) um agente de suspensão à base de argila modificada; (c) um sistema oleoso que compreende: i. um óleo de origem vegetal; ii. um éster de ácido graxo; iii. um hidrocarboneto volátil; et iv. um éter de alquila inferior e de polipropileno glicol. a composição controla os odores corporais e a transpiração sem deixar um resíduo branco visível sobre a pele e/ou colorir uma roupa do usuário final.
Patent EP-1311728-B9 (EP)
Inventor: AUGHTON DAVID
IPC: E02B/
Filed: 2001-08-21
Granted: 2007-11-28
Abstract: The invention provides a control gate (10) adapted to be installed across a channel (12) for liquids. The control gate (10) has a barrier member (76) that is pivotally mounted at or adjacent the base (20) of a flow channel (12). A drive means (34) cooperates with cables (56,58) extending along the barrier member (76) to allow raising and lowering of barrier member (76) to regulate flow of liquid through the control gate (10).
Patent EP-1309498-B9 (EP)
Inventor: LEVY RUTH
IPC: B65D83/08
Filed: 2001-07-12
Granted: 2011-11-16
Abstract: The combination of a package (20) and plural absorbent pads e.g. pantiliners. The pads (22) are folded and stacked on top of one another. The package includes an openable mouth (26) so that the user can grasp one of the pads to remove it from the package. The pads of the stack may be interleaved so that removal of one pad from the package brings a portion of another pad to the mouth to facilitate the removal of that pad from the package.
Patent EP-1648878-B9 (EP)
Inventor: SUN QUN
IPC: C07D417/14
Filed: 2004-07-23
Granted: 2011-03-16
Abstract: Piperidine Compounds; compositions comprising a Piperidine Compound; and methods for treating or preventing pain, UI, an ulcer, IBD, IBS, an addictive disorder, Parkinson's disease, parkinsonism, anxiety, epilepsy, stroke, a seizure, a pruritic condition, psychosis, a cognitive disorder, a memory deficit, restricted brain function, Huntington's chorea, amyotrophic lateral sclerosis, dementia, retinopathy, a muscle spasm, a migraine, vomiting, dyskinesia, or depression in an animal comprising administering to an animal in need thereof an effective amount of a Piperidine Compound are disclosed. In embodiment, the Piperidine Compound has the formula:   
and pharmaceutically acceptable salts thereof, wherein Ar 1 , Ar 2 , X, R 3 , R 4 , and m are as disclosed herein.
Patent EP-1121382-B9 (EP)
Inventor: WHITTY ADRIAN
IPC: C07K17/08
Filed: 1999-10-15
Granted: 2007-07-04
Abstract: A fusion polypeptide is described having the amino acid sequence X-Y-Z, or portion thereof, comprising the amino acid sequence of a glycosylated interferon-beta (X); Y is an optional linker moiety; and Z is a polypeptide comprising at least a portion of a polypeptide other than glycosylated interferon-beta. It is preferred that X is human interferon-beta-1a. Mutants of interferon-beta-1a are also described.
Patent EA-030417-B9 (EA)
Title: Process for the preparation of a sulphur cement product and sulphur cement product prepared by this process
Inventor: VERBIST GUY LODE MAGDA MARIA
IPC: C04B28/36
Filed: 2014-07-31
Abstract: The invention relates to a process for the preparation of a sulphur cement product comprising admixing sulphur, particulate inorganic material and an oligomeric organosilane having one or more terminal groups of general formula (I)wherein Ris a linear or branched hydrocarbyl group having from 2-24 carbon atoms and Ris a linear or branched hydrocarbyl group having from 2-40 carbon atoms, wherein the particulate inorganic material is a filler or a sulphur cement aggregate and admixing all the components is carried out at a temperature at which the sulphur is molten to produce a molten sulphur cement product; and solidifying the molten sulphur cement product. The amount of the oligomeric organosilane which is admixed with sulphur and the particulate inorganic material is in the range of from 0.05 to 1 wt.% based of the weight of sulphur. The product prepared by said process is also disclosed.
Patent DE-102021125572-B9 (DE)
Title: Verfahren zur Durchführung eines Authentisierungsprozesses durch einen individuellen Systembenutzer
Inventor: LEIBRECHT UWE
IPC: H04L9/32
Filed: 2021-10-01
Granted: 2023-08-03
Abstract: Die Erfindung betrifft ein Verfahren zur Durchführung eines Mensch-Maschinen-Authentisierungsprozesses durch einen individuellen Systembenutzer.Es ist die Aufgabe der Erfindung, ein Authentisierungssystem unter Nutzung Hard- und Software umfassender technischer Sicherheitssysteme zur Erzeugung, Verwaltung und Ausführung eines Authentisierungsalgorithmus zu schaffen.Erreicht wird dies nach der Erfindung durch das Implementieren von Sicherheitsfragmenten durch einen Administrator in Form von Mustern und/oder Regelwerken und/oder Algorithmus-Templates, das Verwalten der Sicherheitsfragmente durch den Administrator, das Erzeugen des Algorithmus aus implementierten Sicherheitsfragmenten und Verknüpfen mit einem Authentisierungscode. Der Authentisierungsprozess wird durch eine Legitimation und automatisiertes Generieren von temporären Authentisierungsdaten ausgeführt sowie die Übertragung an den individuellen Systembenutzer ermöglicht, wobei ein Datenaustausch zwischen dem Sicherheitssystem und dem Authentisierungssystem durch Synchronisationsprozesse zum Austausch nicht öffentlicher Daten erfolgt. Die Anwendung des Codes durch den Systembenutzer erfolgt durch Umwandlung der temporären Authentisierungsdaten in einen temporären Eingabecode sowie die Ausführung einer Authentisierungsprüfung durch das technische Sicherheitssystem.